Page last updated: 2024-11-03

propentofylline and Somatoform Disorders

propentofylline has been researched along with Somatoform Disorders in 1 studies

Somatoform Disorders: Disorders having the presence of physical symptoms that suggest a general medical condition but that are not fully explained by another medical condition, by the direct effects of a substance, or by another mental disorder. The MEDICALLY UNEXPLAINED SYMPTOMS must cause clinically significant distress or impairment in social, occupational, or other areas of functioning. In contrast to FACTITIOUS DISORDERS and MALINGERING, the physical symptoms are not under voluntary control. (APA, DSM-V)

Research Excerpts

ExcerptRelevanceReference
"The present study was undertaken to determine whether propentofylline, a glial modulating agent, could both prevent the induction of mechanical allodynia and attenuate existing mechanical allodynia in a rodent L5 spinal nerve transection model of neuropathic pain."3.71Propentofylline, a glial modulating agent, exhibits antiallodynic properties in a rat model of neuropathic pain. ( DeLeo, JA; Schubert, P; Sweitzer, SM, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sweitzer, SM1
Schubert, P1
DeLeo, JA1

Other Studies

1 other study available for propentofylline and Somatoform Disorders

ArticleYear
Propentofylline, a glial modulating agent, exhibits antiallodynic properties in a rat model of neuropathic pain.
    The Journal of pharmacology and experimental therapeutics, 2001, Volume: 297, Issue:3

    Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperalgesia; Immunohistochemistr

2001